Differences in regulatory policies between countries as well as a lack of appropriate 28 standardized methods for authentication and quality control of herbal products lead to 29 concerns over quality and safety. Echinacea products are among the top selling herbal 30 products in Europe and the United States with indications for broad range of ailments. 31 32
abundantly in the aerial parts of E. purpurea and mainly absent in E. pallida roots). E. 122 pallida contains large amounts of ketoalkenes. Rutoside is a flavonoid present in the 123 leaves of all the three species of Echinacea (Barnes et al., 2005) . 124 125
1.4 Quality issues of Echinacea herbal products 126 The increased use of Echinacea species has led to concerns about adulterated 127 products resulting from challenges in morphology-based identification, due to 128 overlapping morphological variability and frequent hybridization between species 129 (Flagel et al., 2008) . Furthermore, reported adulteration of E. purpurea with the roots 130
of Parthenium integrifolium L., Lespedeza capitata Michx., Eryngium aquaticum L., 131
Rudbeckia nitida Nutt., Helianthus annuus L. or Liatris aspera Michx. lead to safety 132 concerns of the herbal products (Zhang et al., 2017) . The use of unreported 133
ingredients is a serious safety concern as adverse drug reactions cannot be associated 134 to the product label and ingredients (Gilbert, 2011) . Commercially available herbal 135 products contain one or more Echinacea species originating from the same or 136 different geographical areas, and the resulting phytochemical diversity across these 137 products can complicate further investigations (Barnes et al., 2005 High phenotypic plasticity within Echinacea has complicated the taxonomy of the 152 genus and led to misidentifications, confused taxonomies and misapplication of taxa 153 (Kindscher and Wittenberg, 2016) . Combined plastid (trnS and trnG) and nuclear 154 (Adh, CesA, and GPAT) phylogenies found no resolved topologies, suggesting 155 incomplete lineage sorting, as well as the potential for widespread hybridization and 156 backcrossing following secondary contact within the genus (Flagel et al., 2008 The countries of origin of these products were Austria (1), China (1), Czech Republic 196
(3), France (1), Germany (4), Italy (2), Macedonia (1), Poland (2), Romania (26), 197
Switzerland (1), United States (7), and four of the products did not specify a country 198 of origin. A list of samples is included as were applied separately in twin bands, on maximum 12 tracks at 4-8 mm distance 246 using different application volumes (4-16 µl for extracts, 12-17 µl for bag and bulk 247 teas, 12-17 µl for tablets, 9-15 µl for capsules and 3-6 µl for standard solutions) with 248 a band length of 8-10 mm and a delivery speed of 8 s/µl using a CAMAG Linomat IV 249 automatic sample applicator (see above). The plates were run for 30 min in the 250 developing box and subsequently dried at 105 °C for 5 min. For phenylpropanoids 251 identification, the plates were inspected at 254 and 366 nm before and after 252 homogenous spraying with the Natural products-polyethylene glycol reagent 253 (NP/PEG), and subsequently air dried. For each set of samples, the plates were 254 developed in a saturated vertical-developing chamber at room temperature (20-22 °C) 255
for 30 min with ethyl acetate:formic acid:acetic acid:water = 20:2.2:2.2:5.4 V/V as 256 mobile phase; the development distance was 7 cm; after the development, the plates 257
were air dried at room temperature. Derivatization of the chromatograms were 258 performed by spraying the plates with NP (0.1 g in 10 ml methanol) and PEG 400 259 (0.5 g in 10 ml ethanol), followed by heating of the plates at 105 °C temperature for 260 15 min. Plates were subsequently imaged using a CAMAG the Table S3 . 312 313
The results of HPTLC chromatographic identifications of the analysed herbal 314 teas yielded the following results for the 10 samples labelled as including Echinacea 315 sp. ( Figure 1A and comparison of the profile with that of the botanical standard E. angustifolia (Figure  327 1A) indicates a mixture of E. purpurea and E. angustifolia. In sample #5 E. purpurea 328 was identified from the distinct presence of cichoric and caftaric acid. 329
The results of the HPTLC chromatographic identifications of the analysed 330 capsules yielded the following ( Figure 1B and Table S4) mixture of E. pallida and E. purpurea ( Figure 1B) . In samples #20 and #25 labelled 342 as including mixtures of E. purpurea and E. angustifolia, the presence of these 343 species was confirmed by the content of echinacoside, caftaric acid, cichoric acid and 344 caffeic acid. 345
The results of the HPTLC chromatographic identifications of the analysed 346 tablets yielded the following ( Figure 1C and Table S4 In sample #42 no Echinacea was identified. 356
The results of the HPTLC chromatographic identifications of the analysed 357 extracts yielded the following ( Figure 1D and to sample. Fifteen samples had a concentration lower than 0.1 ng/μl, 26 samples 370 ranging from 0.1 to 10 ng/μl, and twelve higher than 10 ng/μl. No correlation between 371 obtained DNA concentration and the substrate type of the extracted product was 372 observed (Table S5 ). 373
The raw data before demultiplexing consisted of 12,190,865 sequences, with 374 an average of 115,008 sequences per sample for each marker. After applying our 375
trimming and filtering quality criteria, 38 herbal products (72 %) were retained, and 376 they were used for further analysis (Table S6) including 79,918 nrITS1 reads and 225,100 nrITS2 reads (Table S6 ). The MOTUs 382
were formed using a 99 % similarity clustering threshold, and 2,529 MOTUs that 383 contained minimum 10 reads were retained and further identified using BLAST as 83 384 different species (Table S7 ). For nrITS1 we detected a total of 60 different species 385 and 37 species on only nrITS2 ( The targeted Echinacea species were detected in 34 out of 38 products (89 %) 393 of the retained samples ( Figure 2 and Per formulation category the DNA metabarcoding yielded the following 406 results (cf. Figure 2 and Table S8 ): In thirteen out of 17 samples the presence of 407
Echinacea sp. was confirmed, and in the remaining four samples, three did not yield 408
MOTUs that passed the quality filtering criteria. The capsules contained Echinacea 409 sp. in twelve out of 16 samples, and identification was not possible in four of the 410 products because these did not yield MOTUs that passed the quality filtering criteria. 411
The herbal tables contained Echinacea sp. in only six out of 13 samples, and in the 412 remaining seven samples five did not yield MOTUs that passed the quality filtering 413 criteria. The extracts contained Echinacea sp. in only three out of seven samples, and 414
the remaining four did not yield MOTUs that passed the quality filtering criteria. 415 416 417
4. Discussion 418
The quality and authenticity of herbal products have direct impacts on their safety. 419
Quality control must include a series of procedures to ensure the identity of the used 420 raw materials and screening of target compounds along the value chain. 421 Authentication assays in herbal production must discriminate potential adulterants 422 and/or substitutes. However, despite the existence of well-established and widely 423 accepted analytical methods recommended in the regulatory guidelines (EDQM,  424 2014; EMA, 2006) for herbal product quality assessment, their resolution and efficacy 425 can be impeded by various factors. First, the finished herbal products are often highly 426 processed with numerous ingredients, and even if these analytical methods are 427 accurate in detecting specific target compounds, they have limited efficiency in 428 detecting infrageneric substitution and do not yield any information on other plant 429 ingredients in the products (Rossi Forim et al., 2015) . Morphology based taxonomic 430 methods are equally impeded by highly processed herbal products as these often 431 constitute of finely powdered materials (Zhao et al., 2006) . 432
In this study, we combined HPTLC and DNA metabarcoding. HPTLC is an 433 more automated and reproducible form of thin-layer chromatography (TLC), and with 434 a better separation and detection of the compounds that can be successfully used in Echinacea and other species, which was applied on 53 herbal products in this study, 438
including herbal tea, capsules, tablets and tinctures. The results showed that each of 439 the three targeted Echinacea species have distinguishable chromatograms within most 440 of the herbal products ( Figure 1 ). The main limitation of the HPLTC assay is the 441 inability to offer insights on the presence of other plant species in the herbal product. 442
HPTLC is less suitable to for the analysis of volatile and certain sensitive samples 443 (Morlock and Schwack, 2010) . Combination of HPTLC with methods, such us mass 444 spectrometry (MS), ultraviolet-visible (UV-VIS) and infrared spectrometry (IR) or 445
Fourier-transformed infrared spectroscopy (FTIR) offer further possibilities for 446 analytical refinement in the analysis of herbal products by increasing the amount of 447 qualitative and quantitative information. In summary, HPTLC is not the most 448
adequate method for detection of substitution and adulteration within marketed herbal 449 products, but it is a powerful and cost-effective method to identify specific 450 chemotaxonomic markers, and thus applicable in the quality control of the derived 451 herbal products. The increasing use of herbal medicines needs to be accompanied by an enhanced 504 method for comprehensive quality control that are adequate for all the stages of the 505 supply chain, starting from the cultivation of the raw material to the marketed herbal 506 product. The results of our study show that HPTLC is a reliable analytical tool for 507 routine use to identify and distinguish Echinacea species in herbal products. It allows 508
for better separation and a course quantification of chemical constituents, but it has a 509 limited resolution in detecting the presence of other species within the product. Here, 510
we show that this limitation can be overcome through the complementary use of DNA 511 metabarcoding that simultaneously confirms both the presence of the target species 512 and of all other species, in even highly processed and multi-ingredient herbal 513 products. Advances in sequencing technology advances make the use of DNA 514 metabarcoding promising for large-scale authentication of herbal products. 515
Nevertheless, standardization is required before it can be implemented as a routine 516 complementary analytical method for regulatory quality control and herbal 517 pharmacovigilance. 518 519
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